Hemocompatibility of Super-Repellent surfaces: Current and Future.

ABSTRACT: Virtually all blood-contacting medical implants and devices initiate immunological events in the form of thrombosis and inflammation. Typically, patients receiving such implants are also given large doses of anticoagulants, which pose a high risk and a high cost to the patient. Thus, the design and development of surfaces with improved hemocompatibility and reduced dependence on anticoagulation treatments is paramount for the success of blood-contacting medical implants and devices. In the past decade, the hemocompatibility of super-repellent surfaces (i.e., surfaces that are extremely repellent to liquids) has been extensively investigated because such surfaces greatly reduce the blood-material contact area, which in turn reduces the area available for protein adsorption and blood cell or

SUBMITTER: Movafaghi S 

PROVIDER: S-EPMC6941870 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature